Key findings
• Preoperative anemia does not affect the long-term survival advantage associated with coronary artery bypass grafting (CABG) in patients with ischemic cardiomyopathy (ICM).
What is known and what is new?
• Preoperative anemia is a recognized risk factor for adverse outcomes in CABG, leading some ICM patients to prefer conservative management over surgical intervention.
• Our study provides evidence that, despite the presence of preoperative anemia, the long-term survival advantage of CABG in ICM patients remains intact.
What is the implication, and what should change now?
• The study might support surgeons in advocating for surgical intervention when clinically appropriate, even in anemic patients, ensuring optimal patient outcomes.
Publication: Huang Y, Liu K, Li G, Wu H, Fu G, Jian B, Pan J, Chu T, Zhang Y, Liang M, Zhou Z, Wu Z. Impact of preoperative anemia in ischemic cardiomyopathy with or without coronary artery bypass grafting. J Thorac Dis 2025;17(1):198-208. doi: 10.21037/jtd-24-1187
Observational study
People
Impact of preoperative anemia in ischemic cardiomyopathy with or without coronary artery bypass grafting
22-Jan-2025
All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-1187/coif). The authors have no conflicts of interest to declare.